According to a recent study, tirzepatide and semaglutide offer long-term health benefits but are not cost-effective.

With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help ...

The global weight-loss drug market is expected to reach $150 billion in the next decade. By 2026, semaglutide (the active ...

Eli Lilly launches Mounjaro, the much-awaited diabetes drug, in India. It is priced at ₹3,500 for 2.5 mg. Mounjaro and ...

The new class of weight-loss medicines that has taken the world by a storm will now become available in India, with the ...

Briana Adesso, 31, was a very social person who would routinely go out with friends when she suddenly gained about 40 pounds ...

Stanford Medicine researchers have identified a promising, naturally occurring molecule that could help people lose ...

Kidney transplant recipients with type 2 diabetes treated with a new class of anti-obesity drugs were less likely to ...

The new craze of using lower-than-recommended dosages of weight loss drugs to slim down might sound tempting, says Charlotte ...

BRINP2-related peptide, or BRP, is a naturally occurring molecule that can suppress appetite and promote weight loss in mice and pigs.

Recent research throws into question whether GLP-1 drugs increase the risk of certain types of thyroid cancer.